SKYLER JAY S
SEC insider (Form 3/4/5 filer). CIK 0001236386. Director at Applied Therapeutics, Inc. (APLT) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Feb 3, 2026. Located in NEW YORK, NY.
Companies SKYLER JAY S has filed insider reports for
- Applied Therapeutics, Inc. (APLT): Director
- SAB Biotherapeutics, Inc. (SABS): Director
SKYLER JAY S
CIK: 0001236386
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Feb 3, 2026APLT
Applied Therapeutics, Inc.
DispositionDirect22.5K shares- - Feb 3, 2026APLT
Applied Therapeutics, Inc.
Tender OfferDirect42.5K shares- - Dec 16, 2025SABS
SAB Biotherapeutics, Inc.
AwardDirectStock Option (right to buy)
150K shares- - Jun 9, 2025APLT
Applied Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
200K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 3, 2026 |  APLT Applied Therapeutics, Inc. | Disposition | 22,500 | - | $0 | Direct |
| Feb 3, 2026 | APLT Applied Therapeutics, Inc. | Tender Offer | 42,500 | - | $0 | Direct |
| Dec 16, 2025 |  SABS SAB Biotherapeutics, Inc. | Award Stock Option (right to buy) | 150,000 | - | - | Direct |
| Jun 9, 2025 | APLT Applied Therapeutics, Inc. | Award Stock Option (Right to Buy) | 200,000 | - | - | Direct |
1-4 of 4 transactions